Dermata Therapeutics Inc. Warrant (DRMAW) Live Share Price, Invest From India

Dermata Therapeutics Inc. Warrant Stock Performance

as on May 30, 2026 at 6:39 am IST

$0.01
Day's Price Range
$0.01
$0.01
52 Week's Low
52 Week's High
52-Week Price Range
$0.01
100.00%
Downside
-100.00%
Upside

Dermata Therapeutics Inc. Warrant share price movements today

Previous Close: $0.01
Open: $0.01
Volume: 398.1K
Day's Low - High: $0.01 - $0.01

Dermata Therapeutics Inc. Warrant Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Dermata Therapeutics Inc. Warrant Stock Fundamentals & Key Indicators

Check Dermata Therapeutics Inc. Warrant market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-103.58%

Dermata Therapeutics Inc. Warrant stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Dermata Therapeutics Inc. Warrant with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Dermata Therapeutics Inc. Warrant	NA	$-	NA	NA	0.00%	NA

Dermata Therapeutics Inc. Warrant Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-2	-3	-2	-3	-3	-2	-1	-1	-1	-1
EBITDA	-2	-3	-2	-3	-3	-2	-1	-1	-1	-1
Interest Expense	0	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-3	-2	-3	-3	-2	-1	-1	-1	-1
Income Tax Expense	0	-3	-2	-	3	-	-	-	-	-
Net Income	-2	-3	-2	-3	-3	-2	-1	-1	-1	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dermata Therapeutics Inc. Warrant Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	-	-	-	-	-
Operating Income	-4	-3	-7	-9	-8	-12	-7
EBITDA	-4	-3	-7	-9	0	-12	-7
Interest Expense	0	0	0	0	-	-	-
Depreciation	0	0	-	-	-	-	-
Income Before Tax	-4	-3	-7	-9	-7	-12	-7
Income Tax Expense	0	0	0	0	0	-	-
Net Income	-4	-3	-7	-9	-7	-12	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Dermata Therapeutics Inc. Warrant Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-3	-2	-3	-3	-2	-1	-1	-1	-1
Operating Cash Flow	-2	-2	-3	-2	-1	-2	-1	-1	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	2	4	0	8	0	0	4	1
Change in Cash	-2	0	1	-2	6	-3	-1	2	0

Dermata Therapeutics Inc. Warrant Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-7	-9	-7	-12	-7,558
Operating Cash Flow	-4	-5	-8	-6	-11	-7,757
Investing Cash Flow	-	-	-	-	-	-
Financing Cash Flow	2	15	4	7	6	12,117
Change in Cash	-1	10	-4	1	-4	4,360

About Dermata Therapeutics Inc. Warrant

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Organisation	Dermata Therapeutics Inc. Warrant
Headquarters	3525 Del Mar Heights Rd., San Diego, CA, United States, 92130
Industry	Health Care
CEO	Mr. Gerald T. Proehl
E-voting on shares	Click here to vote

Key Management of Dermata Therapeutics Inc. Warrant

Name	Title
Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.	Senior Vice President of Regulatory Affairs & Quality Assurance
Mr. Gerald T. Proehl	Founder, President, CEO & Chairman
Mr. David F. Hale	Co-Founder & Lead Independent Director
Ms. Kyri K. Van Hoose CPA, M.B.A.	Senior VP & CFO
Dr. Christopher J. Nardo M.P.H., Ph.D.	Senior VP & Chief Development Officer
Mr. Sean Proehl	Associate General Counsel
Ms. Kyra Peckaitis	Vice President of Marketing

FAQs

What is Dermata Therapeutics Inc. Warrant share price today?

Dermata Therapeutics Inc. Warrant share price today is $0.01 as on May 30, 2026 at 1:09 am IST at the close of the market. Dermata Therapeutics Inc. Warrant share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for Dermata Therapeutics Inc. Warrant share?

Dermata Therapeutics Inc. Warrant share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. Dermata Therapeutics Inc. Warrant stock price today i.e. May 30, 2026 at 1:09 am IST is closed at $0.01,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Dermata Therapeutics Inc. Warrant Stock (DRMAW) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Dermata Therapeutics Inc. Warrant on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dermata Therapeutics Inc. Warrant Shares that will get you 150.0000 shares as per Dermata Therapeutics Inc. Warrant share price of $0.01 per share as on May 30, 2026 at 1:09 am IST.

What is the minimum amount required to buy Dermata Therapeutics Inc. Warrant Stock (DRMAW) from India?

Indian investors can start investing in Dermata Therapeutics Inc. Warrant (DRMAW) shares with as little as ₹95 or $1 (as of May 30, 2026 at 1:38 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹950.00 in Dermata Therapeutics Inc. Warrant stock (as per the Rupee-Dollar exchange rate as on May 30, 2026 at 1:38 am IST). Based on Dermata Therapeutics Inc. Warrant share’s latest price of $0.01 as on May 30, 2026 at 1:09 am IST, you will get 1000.0000 shares of Dermata Therapeutics Inc. Warrant. Learn more about fractional shares .